TITLE

Antibiotic Prophylaxis for Cardiac Surgery: Does the Past Predict the Future?

AUTHOR(S)
Zanetti, Giorgio; Platt, Richard
PUB. DATE
May 2004
SOURCE
Clinical Infectious Diseases;5/15/2004, Vol. 38 Issue 10, p1364
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents the authors comments on a meta-analysis, conducted by researcher Maureen K. Bolon and others, in which they found that the risk of surgical sit infection caused by beta-lactam-resistant gram-positive organisms in patients who received prophylaxis with glycopeptides was one-half of that observed for those who received beta-lactam antibiotics. According to the authors, unfortunately, the meta-analysis does not help in choosing a threshold above which glycopeptides should be used for prophylaxis, mainly because precise data on methicillin resistance were not available in the 7 selected studies.
ACCESSION #
13077119

 

Related Articles

  • Marinopyrrole Derivatives as Potential Antibiotic Agents against Methicillin-Resistant Staphylococcus aureus (II). Cheng, Chunwei; Song, Hao; Liu, Yan; Li, Rongshi; Pan, Lili; Li, Jerry; Qin, Yong // Marine Drugs;Aug2013, Vol. 11 Issue 8, following p2927 

    Methicillin-resistant Staphylococcus aureus (MRSA) continues to be a major problem, causing severe and intractable infections worldwide. MRSA is resistant to all beta-lactam antibiotics, and alternative treatments are limited. A very limited number of new antibiotics have been discovered over...

  • Comparative activity of ceftobiprole against Gram-positive and Gram-negative isolates from Europe and the Middle East: the CLASS study. Rossolini, Gian M.; Dryden, Matthew S.; Kozlov, Roman S.; Quintana, Alvaro; Flamm, Robert K.; Läuffer, Jörg M.; Lee, Emma; Morrissey, Ian // Journal of Antimicrobial Chemotherapy (JAC);Jan2011, Vol. 66 Issue 1, p151 

    Objectives To assess the in vitro activity of ceftobiprole and comparators against a recent collection of Gram-positive and Gram-negative pathogens, in order to detect potential changes in susceptibility patterns, and to evaluate the Etest assay for ceftobiprole susceptibility testing. Methods...

  • Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activity. Biek, Donald; Critchley, Ian A.; Riccobene, Todd A.; Thye, Dirk A. // Journal of Antimicrobial Chemotherapy (JAC);Nov2010 Supplement 4, Vol. 65 Issue suppl_4, piv9 

    Ceftaroline fosamil is a novel cephalosporin with broad-spectrum activity against Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA) and multidrug-resistant Streptococcus pneumoniae, and common Gram-negative organisms. The activity of ceftaroline against MRSA...

  • Glycopeptides Are No More Effective than β-Lactam Agents for Prevention of Surgical Site Infection after Cardiac Surgery: A Meta-analysis. Bolon, Maureen K.; Morlote, Monica; Weber, Stephen G.; Koplan, Bruce; Carmeli, Yehuda; Wright, Sharon B. // Clinical Infectious Diseases;5/15/2004, Vol. 38 Issue 10, p1357 

    The article presents information about a meta-analysis that was performed to investigate whether a switch from beta-lactams to glycopeptides for cardiac surgery prophylaxis should be advised. The method of outcome determination was ascertained, including standardized definitions of infection...

  • Oritavancin: A New Opportunity for Outpatient Therapy of Serious Infections. Tice, Alan // Clinical Infectious Diseases;2012 Supplement 3, Vol. 54, pS239 

    Oritavancin is a new antibiotic for the treatment of serious infections with Gram-positive bacteria. It has been shown to be effective against methicillin-susceptible and -resistant Staphylococcus aureus as well as enterococci. With a terminal half-life of 393 hours, oritavancin lends itself to...

  • Ceftobiprole: MRSA Coverage Comes to β-Lactams at Last. Blackburn, Brian G. // Infectious Disease Alert;Jul2008, Vol. 27 Issue 10, p109 

    In the current era of increasing antimicrobial resistance, the need for novel antibacterial agents has become more acute than ever. While complicated skin and skin-structure infections (cSSSIs) are a common scenario, the clinician's ability to choose a single antibacterial agent with reliable...

  • Molecular analysis of methicillin-resistant Staphylococcus pseudintermedius of feline origin from different European countries and North America. Kadlec, Kristina; Schwarz, Stefan; Perreten, Vincent; Andersson, Ulrika Grönlund; Finn, Maria; Greko, Christina; Moodley, Arshnee; Kania, Stephen A.; Frank, Linda A.; Bemis, David A.; Franco, Alessia; Iurescia, Manuela; Battisti, Antonio; Duim, Birgitta; Wagenaar, Jaap A.; Van Duijkeren, Engeline; Weese, J. Scott; Fitzgerald, J. Ross; Rossano, Alexandra; Guardabassi, Luca // Journal of Antimicrobial Chemotherapy (JAC);Aug2010, Vol. 65 Issue 8, p1826 

    The article discusses a study that characterized methicillin-resistant Staphylococcus pseudintermedius (MRSP) isolates from cats in Europe and North America for their genetic relationships and antimicrobial resistance phenotypes and genotypes. The researchers observed that all isolates were...

  • Leuconostoc bacteremia in three patients with malignancies. Ishiyama, Ken; Yamazaki, Hirohito; Senda, Yasuko; Yamauchi, Hiromasa; Nakao, Shinji // Journal of Infection & Chemotherapy (Springer Science & Business;Jun2011, Vol. 17 Issue 3, p412 

    Leuconostoc is a Gram-positive coccus characterized by its resistance to glycopeptide antibiotics. Generally, this bacterium is susceptible to β-lactam antibiotics; however, here we present a leukemia patient who developed leuconostoc bacteremia during antimicrobial therapy with carbapenem....

  • Host range of enterococcal vanA plasmids among Gram-positive intestinal bacteria. Werner, Guido; Freitas, Ana R.; Coque, Teresa M.; Sollid, Johanna E.; Lester, Camilla; Hammerum, Anette M.; Garcia-Migura, Lourdes; Jensen, Lars B.; Francia, Maria V.; Witte, Wolfgang; Willems, R. J.; Sundsfjord, Arnfinn // Journal of Antimicrobial Chemotherapy (JAC);Feb2011, Vol. 66 Issue 2, p273 

    Objectives The most prevalent type of acquired glycopeptide resistance is encoded by the vanA transposon Tn1546 located mainly on transferable plasmids in Enterococcus faecium. The limited occurrence in other species could be due to the lack of inter-species transferability and/or stability of...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics